Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Twilight Venture Partners was a venture capital firm based in Cambridge, Massachusetts, that historically focused on early-stage investments in the life sciences and healthcare sectors. The firm specialized in identifying and supporting innovative biotechnology, medical device, and healthcare information technology companies during their seed and Series A stages. Led by Managing Director Douglas Onsi, the firm provided both capital and strategic guidance to its portfolio companies, which included ventures like Health Dialog and Pericor Science. While the firm is no longer actively seeking new investment opportunities, it remains a significant entity in the history of its principals' careers, particularly as a precursor to their leadership roles in companies like Leap Therapeutics. The firm’s investment strategy emphasized high-growth potential and transformative medical solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Twilight Venture Partners.